Guidance for completing the Drug Submission Application Form
For Drug Identification Number applications, a separate completed HC/SC 3011 must be provided for each formulation, strength and dosage form. For all other submission types, only a separate completed Part 2 must be provided for each formulation, strength and dosage form.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Guidance for completing the Drug Submission Application FormHTMLEnglish publication HTML
-
Guidance for completing the Drug Submission Application FormHTMLFrench publication HTML
Similar records